Serveur d'exploration sur la grippe aux Pays-Bas

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Evaluation of the ESPLINE® Influenza A & B-N assay for the detection of influenza A and B in nasopharyngeal aspirates.

Identifieur interne : 000176 ( Main/Exploration ); précédent : 000175; suivant : 000177

Evaluation of the ESPLINE® Influenza A & B-N assay for the detection of influenza A and B in nasopharyngeal aspirates.

Auteurs : E. De Witte [Belgique] ; H. Goossens ; M. Ieven

Source :

RBID : pubmed:21953031

Descripteurs français

English descriptors

Abstract

Several direct antigen tests for the detection of influenza often lack sensitivity compared to immunofluorescence (IF) on the specimens and viral culture (VC). We evaluated the performance of a rapid test, the ESPLINE® Influenza A & B-N assay. A total of 302 respiratory specimens were collected at the University Hospital of Antwerp. A first group of 60 samples taken during the H1N1 outbreak (2009-2010) and a second group of 242 samples stored during the seasonal influenza epidemics (2000-2009) were analyzed with the ESPLINE® test. A subset of samples were also evaluated with the BinaxNOW Influenza and the Clearview Exact Influenza. The results were compared to IF on the specimens, VC with IF, and the combination of both, which was considered as the gold standard. The ESPLINE® test's overall sensitivity and specificity were 91% and 97%, during the H1N1 season 80% and 93%, and for the detection of seasonal influenza 93% and 97%, respectively. In comparison to the BinaxNOW Influenza and the Clearview Exact Influenza, all tests demonstrated a similar specificity of 92.0-100% but a significantly different sensitivity of 44.4-86.0%, with the ESPLINE® test being significantly more sensitive. Due to its very good performance and simplicity, the ESPLINE® test facilitates urgent testing. The test seems less sensitive to detect H1N1 compared to seasonal influenza, although the difference is borderline not significant (p = 0.067).

DOI: 10.1007/s10096-011-1372-1
PubMed: 21953031


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Evaluation of the ESPLINE® Influenza A & B-N assay for the detection of influenza A and B in nasopharyngeal aspirates.</title>
<author>
<name sortKey="De Witte, E" sort="De Witte, E" uniqKey="De Witte E" first="E" last="De Witte">E. De Witte</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Microbiology, University Hospital Antwerp, Wilrijkstraat 10, 2650, Edegem, Antwerp, Belgium. evy.dewitte@ugent.be</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Microbiology, University Hospital Antwerp, Wilrijkstraat 10, 2650, Edegem, Antwerp</wicri:regionArea>
<wicri:noRegion>Antwerp</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Goossens, H" sort="Goossens, H" uniqKey="Goossens H" first="H" last="Goossens">H. Goossens</name>
</author>
<author>
<name sortKey="Ieven, M" sort="Ieven, M" uniqKey="Ieven M" first="M" last="Ieven">M. Ieven</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:21953031</idno>
<idno type="pmid">21953031</idno>
<idno type="doi">10.1007/s10096-011-1372-1</idno>
<idno type="wicri:Area/Main/Corpus">000191</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000191</idno>
<idno type="wicri:Area/Main/Curation">000191</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000191</idno>
<idno type="wicri:Area/Main/Exploration">000191</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Evaluation of the ESPLINE® Influenza A & B-N assay for the detection of influenza A and B in nasopharyngeal aspirates.</title>
<author>
<name sortKey="De Witte, E" sort="De Witte, E" uniqKey="De Witte E" first="E" last="De Witte">E. De Witte</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Microbiology, University Hospital Antwerp, Wilrijkstraat 10, 2650, Edegem, Antwerp, Belgium. evy.dewitte@ugent.be</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Microbiology, University Hospital Antwerp, Wilrijkstraat 10, 2650, Edegem, Antwerp</wicri:regionArea>
<wicri:noRegion>Antwerp</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Goossens, H" sort="Goossens, H" uniqKey="Goossens H" first="H" last="Goossens">H. Goossens</name>
</author>
<author>
<name sortKey="Ieven, M" sort="Ieven, M" uniqKey="Ieven M" first="M" last="Ieven">M. Ieven</name>
</author>
</analytic>
<series>
<title level="j">European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</title>
<idno type="eISSN">1435-4373</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Clinical Laboratory Techniques (methods)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Infant, Newborn (MeSH)</term>
<term>Influenza A virus (isolation & purification)</term>
<term>Influenza B virus (isolation & purification)</term>
<term>Influenza, Human (diagnosis)</term>
<term>Influenza, Human (virology)</term>
<term>Male (MeSH)</term>
<term>Nasopharynx (virology)</term>
<term>Netherlands (MeSH)</term>
<term>Reagent Kits, Diagnostic (MeSH)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Sensitivity and Specificity (MeSH)</term>
<term>Virology (methods)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (diagnostic)</term>
<term>Grippe humaine (virologie)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Nouveau-né (MeSH)</term>
<term>Partie nasale du pharynx (virologie)</term>
<term>Pays-Bas (MeSH)</term>
<term>Sensibilité et spécificité (MeSH)</term>
<term>Techniques de laboratoire clinique (méthodes)</term>
<term>Trousses de réactifs pour diagnostic (MeSH)</term>
<term>Virologie (méthodes)</term>
<term>Virus de la grippe A (isolement et purification)</term>
<term>Virus influenza B (isolement et purification)</term>
<term>Études rétrospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Reagent Kits, Diagnostic</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Netherlands</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Influenza A virus</term>
<term>Influenza B virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Virus de la grippe A</term>
<term>Virus influenza B</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Clinical Laboratory Techniques</term>
<term>Virology</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Techniques de laboratoire clinique</term>
<term>Virologie</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Partie nasale du pharynx</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
<term>Nasopharynx</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Retrospective Studies</term>
<term>Sensitivity and Specificity</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Pays-Bas</term>
<term>Sensibilité et spécificité</term>
<term>Trousses de réactifs pour diagnostic</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Pays-Bas</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Several direct antigen tests for the detection of influenza often lack sensitivity compared to immunofluorescence (IF) on the specimens and viral culture (VC). We evaluated the performance of a rapid test, the ESPLINE® Influenza A & B-N assay. A total of 302 respiratory specimens were collected at the University Hospital of Antwerp. A first group of 60 samples taken during the H1N1 outbreak (2009-2010) and a second group of 242 samples stored during the seasonal influenza epidemics (2000-2009) were analyzed with the ESPLINE® test. A subset of samples were also evaluated with the BinaxNOW Influenza and the Clearview Exact Influenza. The results were compared to IF on the specimens, VC with IF, and the combination of both, which was considered as the gold standard. The ESPLINE® test's overall sensitivity and specificity were 91% and 97%, during the H1N1 season 80% and 93%, and for the detection of seasonal influenza 93% and 97%, respectively. In comparison to the BinaxNOW Influenza and the Clearview Exact Influenza, all tests demonstrated a similar specificity of 92.0-100% but a significantly different sensitivity of 44.4-86.0%, with the ESPLINE® test being significantly more sensitive. Due to its very good performance and simplicity, the ESPLINE® test facilitates urgent testing. The test seems less sensitive to detect H1N1 compared to seasonal influenza, although the difference is borderline not significant (p = 0.067).</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21953031</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>07</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1435-4373</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>31</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2012</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</Title>
<ISOAbbreviation>Eur. J. Clin. Microbiol. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Evaluation of the ESPLINE® Influenza A & B-N assay for the detection of influenza A and B in nasopharyngeal aspirates.</ArticleTitle>
<Pagination>
<MedlinePgn>761-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10096-011-1372-1</ELocationID>
<Abstract>
<AbstractText>Several direct antigen tests for the detection of influenza often lack sensitivity compared to immunofluorescence (IF) on the specimens and viral culture (VC). We evaluated the performance of a rapid test, the ESPLINE® Influenza A & B-N assay. A total of 302 respiratory specimens were collected at the University Hospital of Antwerp. A first group of 60 samples taken during the H1N1 outbreak (2009-2010) and a second group of 242 samples stored during the seasonal influenza epidemics (2000-2009) were analyzed with the ESPLINE® test. A subset of samples were also evaluated with the BinaxNOW Influenza and the Clearview Exact Influenza. The results were compared to IF on the specimens, VC with IF, and the combination of both, which was considered as the gold standard. The ESPLINE® test's overall sensitivity and specificity were 91% and 97%, during the H1N1 season 80% and 93%, and for the detection of seasonal influenza 93% and 97%, respectively. In comparison to the BinaxNOW Influenza and the Clearview Exact Influenza, all tests demonstrated a similar specificity of 92.0-100% but a significantly different sensitivity of 44.4-86.0%, with the ESPLINE® test being significantly more sensitive. Due to its very good performance and simplicity, the ESPLINE® test facilitates urgent testing. The test seems less sensitive to detect H1N1 compared to seasonal influenza, although the difference is borderline not significant (p = 0.067).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>De Witte</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Microbiology, University Hospital Antwerp, Wilrijkstraat 10, 2650, Edegem, Antwerp, Belgium. evy.dewitte@ugent.be</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Goossens</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ieven</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D023362">Evaluation Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>09</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA>
<NlmUniqueID>8804297</NlmUniqueID>
<ISSNLinking>0934-9723</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011933">Reagent Kits, Diagnostic</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011933" MajorTopicYN="Y">Reagent Kits, Diagnostic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014773" MajorTopicYN="N">Virology</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2011</Year>
<Month>03</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2011</Year>
<Month>07</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>7</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21953031</ArticleId>
<ArticleId IdType="doi">10.1007/s10096-011-1372-1</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Kansenshogaku Zasshi. 2005 Oct;79(10):803-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16296326</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2011 Jan;155(1):163-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20875469</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2007 Jun;39(2):132-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17452000</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2007 Dec;40(4):259-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17977063</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2006 May;78(5):619-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16555288</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2010 Feb;47(2):182-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20022296</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Microbiol. 2010 Apr;59(Pt 4):508-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20075112</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Kansenshogaku Zasshi. 2004 Jul;78(7):597-603</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15359892</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Diagn Lab Immunol. 2005 Mar;12(3):367-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15753248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2010 Jan;48(1):290-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19889892</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diagn Microbiol Infect Dis. 2007 Jan;57(1):67-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17178298</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Belgique</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Goossens, H" sort="Goossens, H" uniqKey="Goossens H" first="H" last="Goossens">H. Goossens</name>
<name sortKey="Ieven, M" sort="Ieven, M" uniqKey="Ieven M" first="M" last="Ieven">M. Ieven</name>
</noCountry>
<country name="Belgique">
<noRegion>
<name sortKey="De Witte, E" sort="De Witte, E" uniqKey="De Witte E" first="E" last="De Witte">E. De Witte</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000176 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000176 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippePaysBasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21953031
   |texte=   Evaluation of the ESPLINE® Influenza A & B-N assay for the detection of influenza A and B in nasopharyngeal aspirates.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21953031" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippePaysBasV1 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 10:18:30 2020. Site generation: Sat Mar 27 13:53:34 2021